Cite
HARVARD Citation
Boni, V. et al. (n.d.). 435PPreliminary results of PROCLAIM-CX-072: The first-in-human, dose-finding trial of PD-L1 probody therapeutic CX-072 as monotherapy in patients (pts) with advanced solid tumors. Annals of oncology. p. . [Online].